Chinook Therapeutics
KDNY
$40.39
Share price
0.00%
Change (1 day)
109.71%
Change (1 year)
Categories
Chinook Therapeutics (KDNY) - P/B ratio
P/B ratio as of May 2024 : 7.58
According to Chinook Therapeutics's latest financial reports the company has a price-to-book ratio of 7.58.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Chinook Therapeutics - P/B ratio (from 2020 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 3.79 | 93.06% |
| 2021-12-31 | 1.96 | -2.03% |
| 2020-12-31 | 2.00 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | -62.24% | 🇺🇸 USA |